DamonRReedMD
Pediatric Hematology & Oncology • New York, NYPediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology
Member, Memorial Hospital Memorial Sloan Kettering Cancer Center Solid Tumor Division Director, MSK Kids President, Connective Tissue Oncology Society Vice Chair, Bone Tumor Committee, COG
Dr. Reed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1275 York Ave
New York, NY 10065Phone+1 813-745-3242- Is this information wrong?
Summary
- Dr. Damon Reed is a pediatric and AYA hematologist/oncologist in New York, NY
Education & Training
University of TennesseeFellowship, Pediatric Hematology/Oncology, 2005 - 2008
Children's Hospital/Boston Medical CenterResidency, Pediatrics, 2002 - 2005
Case Western Reserve University School of MedicineClass of 2002
Certifications & Licensure
FL State Medical License 2008 - 2026
NY State Medical License 2023 - 2025
TN State Medical License 2005 - 2010- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor Start of enrollment: 2010 Sep 01
- SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes Start of enrollment: 2014 Jul 01
- Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma Start of enrollment: 2016 Oct 25
- Join now to see all
Publications & Presentations
PubMed
- "I couldn't connect the wires in my brain." Young adult cancer survivors' experience with cognitive functioning.Danielle B Tometich, Taylor Welniak, Lisa Gudenkauf, Melinda L Maconi, Hayden J Fulton, Dinorah Martinez Tyson, Kellie Zambrano, Syed Hasan, Yvelise Rodriguez, Crystal...> ;Psycho-Oncology. 2024 Mar 1
- Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapy.Darcy L Welch, Brooke L Fridley, Ling Cen, Jamie K Teer, Sean J Yoder, Fredrik Pettersson, Liping Xu, Chia-Ho Cheng, Yonghong Zhang, Mark G Alexandrow, Shengyan Xiang,...> ;Scientific Reports. 2023 Nov 17
- Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031.Thomas Cash, Mark D Krailo, Allen B Buxton, Bruce R Pawel, John H Healey, Odion Binitie, Karen J Marcus, Holcombe E Grier, Patrick J Grohar, Damon R Reed, Aaron R Weis...> ;Journal of Clinical Oncology. 2023 Oct 20
- Join now to see all
Press Mentions
Salarius Pharmaceuticals to Expand Clinical Program to Target Additional Sarcomas in Ewing Sarcoma Phase 1/2 Clinical TrialJuly 29th, 2020
SP-2577 Granted Fast Track Designation by the FDA for Patients with Ewing SarcomaDecember 16th, 2019
Shortage of Critical Cancer Drug Forcing Some Children to Go WithoutOctober 21st, 2019- Join now to see all
Hospital Affiliations
Johns Hopkins All Children's HospitalSaint Petersburg, Florida
Memorial Sloan Kettering Cancer CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
